Loading…
Based on limited metadata, this FDA Warning Letter issued to Claris Injectables Limited on July 5, 2018, pertains to an injectable pharmaceutical product manufacturer. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The warning was issued by the FDA, though the specific issuing office is not identified in the metadata provided. To understand the particular regulatory concerns and required corrective actions, review of the complete warning letter would be necessary.